Literature DB >> 88490

Antibody to early antigens of varicella-zoster virus during varicella and zoster.

G Gerna, P M Cereda, E Cattaneo, G Achilli, M T Gerna.   

Abstract

IgG antibody to the early antigens of varicella-zoster virus (VZV) was studied during both varicella and zoster by the indirect immunoperoxidase antibody technique. In parallel, complement-fixing, immune-adherence hemagglutinating, IgG, and IgM antibodies to VZV were studied. In both varicella and zoster infections, antibody to the early antigens of VZV appeared three to five days after onset of infection, reached a peak during the second week, and progressively decreased in titer until it disappeared, usually within two months. This antibody usually appeared slightly later than IgG or IgM antibody and grossly correlated with IgM antibody in varicella. In zoster infections, IgM antibody to VZV was not found by the immune-adherence hemagglutination assay at a titer of greater than or equal to 1:4, whereas antibody to the early antigens showed a curve similar to that found in varicella. It is suggested that antibody to the early antigens of VZV be considered as a marker of acute VZV infection, which is associated with a specific and significant IgM antibody response in varicella but not in zoster.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88490     DOI: 10.1093/infdis/140.1.33

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Difference in antibody reactivity between complement fixation and immune adherence hemagglutination tests with virus antigens.

Authors:  S Inouye; S Matsuno; R Kono
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

2.  Detection of antibodies to Epstein-Barr virus capsid antigen by immune adherence hemagglutination.

Authors:  E T Lennette; E Ward; G Henle; W Henle
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

3.  Antibody response of patas monkeys to experimental infection with Delta herpesvirus.

Authors:  G Achilli; A Sarasini; G Gerna; J P Iltis; D L Madden
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

4.  Immunofluorescence and immunoperoxidase techniques for detecting antibodies to malignant catarrhal fever in infected cattle.

Authors:  P B Rossiter
Journal:  Trop Anim Health Prod       Date:  1981-11       Impact factor: 1.559

5.  Antibody response against early antigens in Herpesviridae infections.

Authors:  M P Landini
Journal:  Eur J Epidemiol       Date:  1985-03       Impact factor: 8.082

6.  Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus.

Authors:  J P Iltis; G A Castellano; P Gerber; C Le; L K Vujcic; G V Quinnan
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

7.  Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients.

Authors:  M Arsenakis; J T May
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Antibody to human adenovirus early antigens during acute adenovirus infections.

Authors:  G Gerna; E Cattaneo; M G Revello; M Battaglia; G Achilli
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.

Authors:  A M Arvin; C M Koropchak
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

10.  Clinical, virologic, and serologic evidence of Epstein-Barr virus infection in association with childhood pneumonia.

Authors:  W A Andiman; P McCarthy; R I Markowitz; D Cormier; D M Horstmann
Journal:  J Pediatr       Date:  1981-12       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.